Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects
Clinical trial NCT04679129 · COMPLETED
Trial details
- NCT number
- NCT04679129
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-05-03
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.